Newsflash:
- Lilly Ends Alzheimer's Drug Study on Safety Concern
- Osteoporosis Drug Xgeva Approved by FDA to Treat Giant Cell Bone Tumors
- High Prevalence of NSAID Prescription in Those at Risk of Heart Attack/Death in Primary Care
- Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data From Phase 2 Open-Label Study of Investigational Agent Elotuzumab
- Updated Results of Two Phase 2 Ibrutinib Studies in Patients With Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
- New Long-Term Data Reinforce Safety Profile of Pradaxa for Stroke Prevention in AF
Industry News
The latest product information direct from the source – manufacturers and suppliers.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
